Empower Genomics with Proteomics

Landmark Papers

Why should you add proteomics to your current genomics research program?

Being able to profile 1000’s of proteins at scale and identify of accurate pQTLs provides the vital link to combine proteomics to genomics.

This detailed white paper describes how the integration of genomics and proteomics data heralds a new era of discovery. Data from the landmark UK Biobank – Pharma Proteomics Project, as well as the SCALLOP consortium have identified many new pQTLs (protein Quantitative Trait Loci) which are the-associations between genetic variants and circulating protein levels. 

Learn how: 

  • Population scale proteogenomic projects are now delivering a wealth of actionable data to drive future drug development.
  • To identify novel disease biomarkers and new drug targets leading to more effective medicines
  • To determine new mechanisms of action
  • To drive reclassification of diseases and understand the mechanisms of disease pathophysiology

Download your free copy “Empower Genomics with Proteomics" white paper today. 

land-mark-white-paper

Download the white paper now